Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Versailles Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Adult aged at least 18 years old
* Having received (at least) two injections of anti-SARS-CoV-2 messenger RNA vaccine (Pfizer and / or Moderna)
* Affiliated to social security
* consenting to the study
* Concerning cases only: Be or have been affected by B-NHL in remission, active surveillance or during first-line or second-line treatment, regardless of this treatment
You may not be if
Patient less than 18 years old
Patient with protective measure (curatorship, guardianship, safeguard of justice, deprived of liberty, in an emergency situation)
Patient unable to express their consent
Pregnant or breastfeeding woman
Patient refusing to participate
Concerning cases: Patient whose life expectancy related to B-NHL is less than 6 months, History of allogeneic hematopoietic stem cell transplantation, Patient with CART cells treatment
Clareo Health | Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin Lymphoma
